RIM
BIIB icon

Rockbridge Investment Management’s Biogen BIIB Stock Holding History

Rockbridge Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5
Closed -$1.02K – 157
2022
Q2 		$1.02K Hold
5
– – ﹤0.01% 572
2022
Q1 		$1.05K Hold
5
– – ﹤0.01% 729
2021
Q4 		$1K Hold
5
– – ﹤0.01% 754
2021
Q3 		$1K Sell
5
-15
-75% -$4.92K ﹤0.01% 701
2021
Q2 		$7K Sell
20
-19
-49% -$5.76K ﹤0.01% 566
2021
Q1 		$11K Sell
39
-6
-13% -$1.62K ﹤0.01% 488
2020
Q4 		$11K Hold
45
– – ﹤0.01% 488
2020
Q3 		$13K Hold
45
– – ﹤0.01% 438
2020
Q2 		$12K Buy
+45
New +$13.5K ﹤0.01% 403

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Rockbridge Investment Management's BIIB Position: Q3 2022 in Review

Rockbridge Investment Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 5 shares — an estimated $1.02K sold.

Rockbridge Investment Management first reported a position in BIIB in Q2 2020 and held it in 9 quarters. The position peaked at $13K in Q3 2020. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Rockbridge Investment Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • Rockbridge Investment Management sold 5 Biogen shares in Q3 2022, an estimated $1.02K.
  • Rockbridge Investment Management first reported a position in Biogen in Q2 2020 and held it in 9 quarters.
  • Rockbridge Investment Management's Biogen position peaked at $13K in Q3 2020.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Rockbridge Investment Management's 13F filing for Q3 2022, filed 28 May 2024.